Medocity to Present at the 31st Annual Piper Jaffray Healthcare Conference
During the session, Mr. Agarwal will present a company overview and discuss Medocity’s mission to transform management of chronic or complex disease through best-in-class digital care technology and applied artificial intelligence. He also will take questions from the audience following the presentation.
The Piper Jaffray Healthcare Conference will showcase senior management teams from 374 leading public and private companies delivering presentations to an audience of more than 2,500 institutional asset managers, private equity and venture capital investors. This year’s three-day conference will host more than 2,000 private one-on-one meetings with company management. Presenting companies represent several healthcare sectors, including: biotechnology, specialty pharmaceuticals, medical technology, medical diagnostics, and healthcare IT & services.
Medocity is the leading healthcare technology company transforming management of chronic or complex disease. The Medocity Care Platform is the next generation in early and proactive intervention, enabling our clients to deliver comprehensive digital care for patients with any condition, anywhere in the world. Our award-winning solution connects all stakeholders in care, continuously monitors patient-reported data from hundreds of sources, and applies artificial intelligence to identify anomalies, send out alerts, and intervene when necessary — all in real time, through one common ecosystem. Clinically proven across multiple chronic conditions and settings, the Medocity Platform increases engagement, improves outcomes and lowers total healthcare costs.
For more information, please visit www.medocity.com
About Piper Jaffray
Piper Jaffray Companies (NYSE: PJC) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Jaffray & Co., member SIPC and FINRA; in Europe through Piper Jaffray Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Jaffray Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through four separate investment advisory affiliates. U.S. Securities and Exchange Commission (SEC) registered Piper Jaffray Investment Management LLC, PJC Capital Partners LLC and Piper Jaffray & Co., and Guernsey-based Parallel General Partners Limited, authorized and regulated by the Guernsey Financial Services Commission.